Réanimation

, Volume 20, Supplement 2, pp 566–575

Infections communautaires graves — Les pneumonies aiguës communautaires bactériennes de l’adulte

  • D. Berdyev
  • R. Scapin
  • C. Labille
  • L. Lambin
  • M. Fartoukh
Enseignement Supérieur en Soins Infirmiers
  • 210 Downloads

Serious community infections — Acute bacterial community-acquired pneumonia in adults

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171(4):388–416CrossRefGoogle Scholar
  2. 2.
    No authors] (1998) ERS task force report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society. Eur Respir J 11:986–991Google Scholar
  3. 3.
    Mandell LA, Marrie TJ, Grossman RF, et al (2000) Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 31:383–421CrossRefPubMedGoogle Scholar
  4. 4.
    British Thoracic Society Standards of Care Committee (2001) BTS Guidelines for the management of community-acquired pneumonia in adults. Thorax 56(Suppl 4):IV1–64Google Scholar
  5. 5.
    Mandell LA, Bartlett JG, Dowell SF, et al (2003) Update of practice Guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37: 1405–1433CrossRefPubMedGoogle Scholar
  6. 6.
    No authors] (2006) Prise en charge des infections des voies respiratoires basses de l’adulte immunocompétent. XVe Conférence de consensus en thérapeutique anti-infectieuse. Rev Mal Respir 23:13S131–140Google Scholar
  7. 7.
    Niederman MS, Mandell LA, Anzueto A, et al (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med 163:1730–1754PubMedGoogle Scholar
  8. 8.
    Huchon G, Woodhead MA, Gialdoni-Grassi G, et al (1998) Guidelines for management of adult community-acquired lower respiratory tract infections. Eur Respir J 11:986–991CrossRefGoogle Scholar
  9. 9.
    Macfarlane JT, Boldy D (2004) 2004 update of BTS pneumonia guidelines: what’s new? Thorax 59(5):364–366CrossRefPubMedGoogle Scholar
  10. 10.
    Mandell LA, Wunderink RG, Anzueto A, et al (2007) Infectious Diseases Society of America/American Thoracic Society Consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(2):S27–S72CrossRefPubMedGoogle Scholar
  11. 11.
    Woodhead M, Blasi F, Ewig S, et al (2005) Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26:1138–1180CrossRefPubMedGoogle Scholar
  12. 12.
    Niederman MS, Bass JB Jr, Campbell GD, et al (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 148:1418–1426PubMedGoogle Scholar
  13. 13.
    Baddour LM, Yu VL, Klugman KP, et al (2004) Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 170:440–444CrossRefPubMedGoogle Scholar
  14. 14.
    Fine MJ, Auble TE, Yealy DM, et al (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336(4):243–250CrossRefPubMedGoogle Scholar
  15. 15.
    Pallares R, Linares J, Vadillo M, et al (1995) Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 333:474–480CrossRefPubMedGoogle Scholar
  16. 16.
    Austrian R, Gold J (1964) Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med 60:759–776PubMedGoogle Scholar
  17. 17.
    Moine P, Vercken JB, Chevret S, et al (1994) Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. French Study Group for community-acquired pneumonia in the intensive care unit. Chest 105:1487–1495CrossRefPubMedGoogle Scholar
  18. 18.
    Pachon J, Prados MD, Capote F, et al (1990) Severe community-acquired pneumonia. Am Rev Respir Dis 142:369–373PubMedGoogle Scholar
  19. 19.
    Torres A, Serra-Battles J, Ferrer A, et al (1991) Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis 144:312–318PubMedGoogle Scholar
  20. 20.
    Bordon J, Peyrani P, Brock GN, et al (2008) The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia. Results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Chest 133:618–624CrossRefPubMedGoogle Scholar
  21. 21.
    Ewig S, Schafer H, Torres A (2000) Severity assessment in community-acquired pneumonia. Eur Respir J 16:1193–1201CrossRefPubMedGoogle Scholar
  22. 22.
    Fine MJ, Smith MA, Carson CA, et al (1996) Prognosis and outcomes of patients with community-acquired pneumonia. A metaanalysis. JAMA 275(2):134–141CrossRefPubMedGoogle Scholar
  23. 23.
    Fine MJ, Medsger AR, Stone RA, et al (1997) The hospital discharge decision for patients with community-acquired pneumonia. Results from the pneumonia patient outcomes research team cohort study. Arch Intern Med 157(1):47–56CrossRefPubMedGoogle Scholar
  24. 24.
    Metlay JP, Fine MJ (2003) Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med 138:109–118PubMedGoogle Scholar
  25. 25.
    Ewig S, Ruiz M, Mensa J, et al (1998) Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med 158:1102–1108PubMedGoogle Scholar
  26. 26.
    Metlay JP, Hofmann J, Cetron MS, et al (2000) Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 30(3): 520–528CrossRefPubMedGoogle Scholar
  27. 27.
    Mortensen EM, Coley CM, Singer DE, et al (2002). Causes of death for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team cohort study. Arch Intern Med 162(9):1059–1064CrossRefPubMedGoogle Scholar
  28. 28.
    Mortensen EM, Kapoor WN, Chang CC, Fine MJ (2003) Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis 37(12):1617–1624CrossRefPubMedGoogle Scholar
  29. 29.
    Lim WS, van der Eerden MM, Laing R, et al (2003) Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58(5):377–382CrossRefPubMedGoogle Scholar
  30. 30.
    Leroy O, Santré C, Beuscart C, et al (1995) A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 21(1):24–31CrossRefPubMedGoogle Scholar
  31. 31.
    Rello J, Quintana E, Ausina V, et al (1993) A three-year study of severe community-acquired pneumonia with empphasis on outcome. Chest 103:232–235CrossRefPubMedGoogle Scholar
  32. 32.
    Rello J, Rodriguez R, Jubert P, et al (1996) Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Clin Infect Dis 23:723–728PubMedGoogle Scholar
  33. 33.
    Ruiz M, Ewig S, Marcos MA, et al (1999) Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 160(2):397–405PubMedGoogle Scholar
  34. 34.
    Ewig S, Torres A (1999) Severe community-acquired pneumonia. Clin Chest Med 20:575–587CrossRefPubMedGoogle Scholar
  35. 35.
    Angus DC, Marrie TJ, Obrosky DS, et al (2002) Severe community-acquired pneumonia. Use of intensive care services and evaluation of American and British Thoracic Society criteria. Am J Respir Crit Care Med 166(5):717–723CrossRefPubMedGoogle Scholar
  36. 36.
    Ewig S, de Roux A, Bauer T, et al (2004) Validation of predictive rules and indices of severity for community-acquired pneumonia. Thorax 59:421–427CrossRefPubMedGoogle Scholar
  37. 37.
    Roson B, Carratala J, Fernandez-Sabe N, et al (2004) Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med 164(5):502–508CrossRefPubMedGoogle Scholar
  38. 38.
    Fine MJ, Smith MA, Carson CA, et al (1996) Prognosis and outcomes of patients with community-acquired pneumonia. A metaanalysis. JAMA 275(2):134–141CrossRefPubMedGoogle Scholar
  39. 39.
    Feikin DR, Schuchat A, Kolczak MS (2000) Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997. Am J Pub Health 90:223–229CrossRefGoogle Scholar
  40. 40.
    Plouffe JF, Breiman RF, Facklam RR (1996) Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. JAMA 275:194–198CrossRefPubMedGoogle Scholar
  41. 41.
    Hilbert G, Gruson D, Vargas F, et al (2001) Non-invasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344(7):481–487CrossRefPubMedGoogle Scholar
  42. 42.
    Maitre B, Jaber S, Maggiore SM, et al (2000) Continuous positive airway pressure during fiberoptic bronchoscopy in hypoxemic patients. A randomized double-blind study using a new device. Am J Respir Crit Care Med 162:1063–1067PubMedGoogle Scholar
  43. 43.
    Meehan TP, Weingarten SR, Holmboe ES, et al (2001) A statewide initiative to improve the care of hospitalized pneumonia patients: the Connecticut Pneumonia Pathway Project. Am J Med 111(3):203–210CrossRefPubMedGoogle Scholar
  44. 44.
    Meehan TP, Fine MJ, Krumholz HM, et al (1997) Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 278(23):2080–2084CrossRefPubMedGoogle Scholar
  45. 45.
    Arancibia F, Ewig S, Martinez JA, et al (2000) Antimicrobial treatment failures in patients with community-acquired pneumonia. Causes and prognostic implications. Am J Respir Crit Care Med 162(1):154–160PubMedGoogle Scholar
  46. 46.
    Menendez R, Torres A, Zalacain R, et al (2004) Risk factors for treatment failure in community-acquired pneumonia: implication for disease outcome. Thorax 59(11):960–965CrossRefPubMedGoogle Scholar
  47. 47.
    Menendez R, Torres A (2007) Treatment failure in community-acquired pneumonia. Chest 132(4):1348–1355CrossRefPubMedGoogle Scholar
  48. 48.
    Confalonieri M, Urbino R, Potena A, et al (2005) Hydrocortisone infusion for severe community-acquired pneumonia. A preliminary randomized study. Am J Respir Crit Care 171(3):242–248CrossRefGoogle Scholar
  49. 49.
    Laterre PF, Garber G, Levy H, et al (2005) Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study. Crit Care Med 33(5):952–961CrossRefPubMedGoogle Scholar

Copyright information

© Société de réanimation de langue française (SRLF) 2011

Authors and Affiliations

  • D. Berdyev
    • 1
    • 2
  • R. Scapin
    • 1
    • 2
  • C. Labille
    • 1
    • 2
  • L. Lambin
    • 1
    • 3
  • M. Fartoukh
    • 1
  1. 1.Service de pneumologie et réanimationHôpital Tenon AP-HPParisFrance
  2. 2.Équipe de réanimationHôpital Tenon, AP-HPParisFrance
  3. 3.Endoscopies bronchiquesHôpital Tenon, AP-HPParisFrance

Personalised recommendations